摘要：EANM（欧洲核医学学会）官方出版物，致力于推动核医学及其相关学科的发展，打造全球核医学领域的领军期刊。重点关注诊疗一体化、诊断核医学、放射性药物以及用于诊断和治疗的成像探针等方向，发表高质量、高影响力的研究内容。

欧洲核医学学会（EANM）倾力打造两本线上开放获取期刊The EANM Journal和EANM Innovation面向全球核医学及相关领域研究者诚邀稿件！

The EANM Journal

01

EANM（欧洲核医学学会）官方出版物，致力于推动核医学及其相关学科的发展，打造全球核医学领域的领军期刊。重点关注诊疗一体化、诊断核医学、放射性药物以及用于诊断和治疗的成像探针等方向，发表高质量、高影响力的研究内容。

EANM Innovation

02

一本具备前瞻性的开放获取期刊，旨在推动核医学领域的创新与合作。聚焦临床前与临床研究、技术创新，涵盖放射性药物和成像探针在诊断与治疗中的应用。欢迎原创研究、系统综述、实践指南、短篇通讯、病例报道及热点文章等多种文章形式。

核心优势

✨ 广泛的国际传播力与开放获取

✨ 顶尖专家担任同行评审

✨ 专注核医学卓越与创新的权威平台

✨ 免收文章出版费（APC）

EANM期待与您携手推动核医学发展！

Dear all,

We invite you to submit your research to our two dedicated journals:

The EANM Journal – the official publication of EANM, dedicated to advancing nuclear medicine as the world’s leading journal in this field and its allied sciences. It publishes high-quality, impactful scientific content with a focus on theranostics and diagnostic nuclear medicine, radiopharmaceuticals, and imaging probes for both diagnosis and therapy.

EANM Innovation – a forward-looking, open access journal fostering innovation and collaboration in nuclear medicine. It focuses on clinical, preclinical, and technological studies advancing the use of radiopharmaceuticals and imaging probes for diagnosis and therapy, and welcomes original research, systematic reviews, practice guidelines, short communications, case series, and hotspot articles.

By publishing with us, your work benefits from:

Broad international visibility and open access.

Expert peer review by leading specialists.

A platform fully dedicated to excellence and innovation in nuclear medicine.

Free article publishing charge (APC).

Share your findings with the global community. Submit your manuscript today:

The EANM Journal:

来源：云阳好先生做实事